What are the advantages and disadvantages of stem cell transplantation for leukemia?

stem cell transplantation is a medical method of 21st century used to treat various conditions, including cancer such as leukemia. With increasing research of stem cell technology, the procedure has expanded. Attorneys argue for the promising results of the procedure, the restoration of healthy cells and reliance on the latest scientific technology. The disadvantages of stem cell transplantation to leukemia, on the other hand, include the possibility of rejecting the body, the risks of the donor, the difficulty of the localization of the donor and the potential side effects. Stem cells

have a unique potential for developing into any type of cell in the human body. Because stem cells are undifferentiated, scientists believe that they can manipulate cells into brain cells, bone cells or even heart cells. In the case of treatment of leukemia, the desired goal of generating healthy blood cells and immune cells. When doctors use stem cells to treat leukemia, the rate of remission can improve 10 to 40 percent, according to some medical studies.

Research and healthcare facilities all over the world advocated, invested and revolutionized stem cell technology. Applications have been shown to be more than 60 health conditions: heart attacks, spinal cord injuries, youthful diabetes, different types of cancer and many other conditions. Cells extracted from corpses, bone marrow, umbilical blood and even human skin showed remarkable generative capacity. These cells can then be used in two types of stem cell transplants. Autologous transplantation uses the patient's own stem cells, while allogeneic transplantation requires stem cell donors.

Another main benefit of stem cell transplantation for leukemia is the ability to suppress the adverse effects of more intensive cancer treatment. In addition to normal cells, chemotherapy and radiation therapy may damage or kill normal cells. High doses required from treatment withHe is particularly punished on marrow cells. Stem cell transplantation can supplement these cells.

One possible failure for stem cell transplantation for leukemia is the availability of the corresponding donor. In the case of autologous transplantation, the patient's body may be too weak on self-gate. The cells must also be harvested from the patient after the patient has already entered remission. Placing the donor allogeneic transplantation can be even more difficult, as the most effective donors are siblings of the corresponding type of tissue. If the donor cannot be found within the family, doctors must search the register with a possible waiting list.

stem cell transplantation for leukemia could also pose a slight risk for donors depending on its existing health. Stem cells can be harvested from a pulp or blood. A large number of these substances may be needed, as it must circulate with the machine in order enough stem cells. As with any medical procedure, they may result inUT complications such as side effects on medicines.

The

failure of the procedure is perhaps the greatest fear of transplantation of stem cells for leukemia. The rejection of stem cells may develop a serious condition known as Štěpu-Versus disease and the previous relapse is consideration of the probability of rejection. The patient of leukemia may still face long radiation and chemotherapy prior to stem cell transplantation. These procedures can help reduce the risk of immune cells of the body rejection of stem cells.

Further complications of stem cell transplantation may also result. The body is highly vulnerable during the recovery period, which may take several weeks to generate new cells. Other possible effects include hair loss, skin changes, fatigue, muscle pain, hormonal problems, bloodsrains and infections. The healthcare professional can best develop these and other disadvantages as well as the advantages of stem cell transplantation for leukemia.